Benjamin Marwedel

Mr. Benjamin Marwedel

Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ANAchraf Noureddine
Achraf Noureddine
Benjamin MarwedelBenjamin Marwedel
Benjamin Marwedel
LTLien Tang
Lien Tang
LMLorel Y. Medina
Lorel Y. Medina
RSRita Elena Serda
Rita Elena Serda
Immunogenic lipid-coated mesoporous silica nanoparticles (ILM) present pathogen-associated molecular patterns (PAMPs) on the nanoparticle surface to engage pathogen-associated receptors on immune cells. The mesoporous core is capable of loading additional immunogens, antigens or drugs. In this study, the impact of lipid composition, surface potential and intercalation of lipophilic monophosphoryl lipid A (MPL-A) in the lipid coat on nanoparticle properties and cellular interactions is presented. Loading and retention of the model antigen ovalbumin into the mesoporous silica core were found to be similar for all nanoparticle formulations, with presentation of ova peptide (SIINFEKL) by major histocompatibility complex (MHC) evaluated to facilitate the selection of an anionic nanoparticle composition. ILM were able to induce lysosomal tubulation and streaming of lysosomes towards the cell surface in dendritic cells, leading to an enhanced surface presentation of MHC. Myeloid cells robustly internalized all ILM formulations; however, non-myeloid cells selectively internalized cationic ILM in vitro in the presence of 20% serum. Interestingly, ILM administration to the peritoneal cavity of mice with disseminated ovarian cancer resulted in selective accumulation of ILM in tumor-associated tissues (>80%), regardless of nanoparticle surface charge or the presence of MPL-A. Immunofluorescence analysis of the omental tumor showed that ILMs, regardless of surface charge, were localized within clusters of CD11b+ myeloid cells 24 h post administration. Selective uptake of ILMs by myeloid cells in vivo indicates that these cells outcompete other cell populations in the ovarian tumor microenvironment, making them a strong target for therapeutic interventions.

4 October 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
LTLien Tang
Lien Tang
Benjamin MarwedelBenjamin Marwedel
Benjamin Marwedel
CDCaleb Dang
Caleb Dang
MOMarian Olewine
Marian Olewine
MJMelanie Jun
Melanie Jun
ANAchraf Noureddine
Achraf Noureddine